Contracts › 75N95025F00001
75N95025F00001: Biologics Idiq Task Order- Non-Glp Toxicity and Toxicokinetic Studies in Rodents and Non-Rodents for a Novel, Subcutaneously-Dosed Modified-Heparin Drug
Awarded to Battelle Memorial Institute by National Institutes of Health (NIH).
$1.0Mobligated
$1.0Mpotential value
28 March 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N95025F00001 |
|---|---|
| Vehicle | 75N95022D00021 |
| Awardee | Battelle Memorial Institute |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | OH |
| Offers received | 2 |
| Period of performance | 29 September 2025 to 28 March 2028 |
| Potential end | 28 March 2028 |
| Estimated recompete solicitation | ~Q3 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record